NINDS to Fund Biomarkers for Spinal Muscular Atrophy | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Neurological Disorders and Stroke plans to award a $1.8 million grant next year to fund a study to evaluate biomarkers for spinal muscular atrophy (SMA).

SMA occurs in around 1 in 6,000 live births, is associated with a mutation in chromosome 5, and is among the most common genetic causes of infantile death.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.